The Rise of Adult ADHD Diagnoses & The Future of Telehealth Care

Adult ADHD diagnoses are climbing at record rates in the U.S.—but what’s driving this surge, and what does it mean for the future of care? At the same time, new clinical guidelines and upcoming telehealth prescribing regulations are reshaping how clinicians can diagnose and treat ADHD.

Join Dr. Mina Boazak, Founder and Medical Director of Animo Sano Psychiatry, for a timely discussion on:

• Why adult ADHD diagnoses are rising and how new guidelines aim to improve accuracy.
• The role telehealth has played in making evaluations more accessible.
• How proposed DEA prescribing rules could impact access to stimulant medications.
• Safeguards against overdiagnosis in telehealth and digital care models.
• Equity concerns and who may be most affected by regulatory changes.
• How technology and policy can work together to ensure ADHD care remains accessible and high-quality.

September 25 at 5 PM ET

Whether you’re a clinician, advocate, or living with ADHD, this conversation will help you understand the shifting landscape of adult ADHD care and what lies ahead.

Join the discussion.